Citi Turns Bearish on Moderna After 600% Stock Surge
Citi has issued a sell recommendation on Moderna, arguing that revenue and profit forecasts cannot justify a share price that has already gained more than 600%.
Topic
Moderna
Topic
Topic
Topic
Citi has issued a sell recommendation on Moderna, arguing that revenue and profit forecasts cannot justify a share price that has already gained more than 600%.